Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply ...
Find out how scientists are maximizing retinal organoid effectiveness to sustain critical retinal ganglion cells.
Researchers from Bonn and Basel have developed a new method to equip human retinal organoids – small, lab-grown models of the ...
Researchers from Bonn and Basel have developed a new method to equip human retinal organoids – small, lab-grown models of ...
Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply of nutrients and oxygen in ...
For decades, restoring sight after severe eye damage sat firmly in the realm of science fiction. Now a wave of converging ...
Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 ...
Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing in the registrational PIONEER program across 2 key ...
Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing ...
The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...